Activist Shareholder BBRC Escalates Proxy Fight, Urges Vote Against Board Chair Donna James
VSCO has more than doubled off its 52-week low of $17.53.
Summary
Activist shareholder BBRC International, holding a 13% stake, intensified its proxy contest against Victoria's Secret, urging shareholders to vote against Board Chair Donna James due to alleged underperformance and past oversight failures.
Key Events · Corporate Governance and Compliance · VSCO
-
Proxy Contest Escalation
BBRC International, a 13% owner, issued additional soliciting material to intensify its campaign against the re-election of Board Chair Donna James.
-
Allegations of Underperformance
BBRC cites Ms. James's 25-year tenure, highlighting alleged misallocation of $625 million in stock repurchases, the failed $591 million Adore Me acquisition, and a 70%+ stock decline.
-
Past Governance Failures Cited
BBRC reminds stockholders that Ms. James chaired the L Brands Audit Committee from 2005-2019, during which a lawsuit related to the Les Wexner-Jeffrey Epstein relationship resulted in a $90 million settlement and governance reforms.
-
Director Departure Validates Case
BBRC notes that director Mariam Naficy's decision not to stand for re-election validates their call for change, but states it is insufficient to address governance concerns.
Analysis · VSCO · Trade & Services
This filing represents a significant escalation in the ongoing proxy contest initiated by BBRC International, a 13% shareholder. The activist investor is directly challenging the re-election of Board Chair Donna James, citing a long history of alleged underperformance, failed capital allocation decisions, and past governance failures, including her role as Audit Committee Chair during the L Brands-Jeffrey Epstein lawsuit. The outcome of this proxy vote could lead to a material change in the company's board leadership and strategic direction.
At the time of this filing, VSCO was trading at $45.19 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $17.53 to $66.89. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.